# Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

Study · id `cardio:ct-nct04298723` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04298723](<https://clinicaltrials.gov/study/NCT04298723>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04298723

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 530 participants.

## Technical summary

Registry record NCT04298723. Randomized; single masking; primary purpose prevention. Start 2020-06-16 (actual); primary completion 2029-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 530 participants (planned count; ClinicalTrials.gov record NCT04298723, source copy `cardio:ctgov-nct04298723-2026-08-06`, retrieved 2026-10-26)
- Started: 2020-06-16 (actual) (ClinicalTrials.gov record NCT04298723, source copy `cardio:ctgov-nct04298723-2026-08-06`, retrieved 2026-10-26)
- Primary completion: 2029-06 (anticipated) (ClinicalTrials.gov record NCT04298723, source copy `cardio:ctgov-nct04298723-2026-08-06`, retrieved 2026-10-26)
- Completion: 2029-12 (anticipated) (ClinicalTrials.gov record NCT04298723, source copy `cardio:ctgov-nct04298723-2026-08-06`, retrieved 2026-10-26)
- Countries: Germany; Poland (ClinicalTrials.gov record NCT04298723, source copy `cardio:ctgov-nct04298723-2026-08-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04298723-2026-08-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
- Acronym: CLEARANCE
- Condition: Intracranial Hemorrhages
- Condition: Atrial Fibrillation (AF)
- Condition: Atrial Flutter
- Intervention (Device): Percutaneous closure of the LAA (Watchman / Watchman FLX)
- Lead sponsor: Jena University Hospital
- Lead sponsor class: OTHER
- Collaborator: KCRI
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry lists this organization as the lead sponsor: Jena University Hospital (`cardio:org-jena-university-hospital`)

## Provenance

Content hash: 20b366bf77b655e1fa230b1e1a7785291336efbbba6c230a38ba8facbc1cf0eb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
